AI in Healthcare August 13, 2021
Dave Pearson

Researchers have used deep learning to assess three key biomarkers of existing breast cancers on routinely acquired histology slides. In the process, the team has advanced AI-based biomarker analysis for managing a range of cancers.

The breakthrough comes as part of an ongoing research project led by Google Health in collaboration with Naval Medical Center San Diego and the Henry M. Jackson Foundation for the Advancement of Military Medicine. It’s described in a study published Aug. 14 in Communications Medicine.

When scored together, the three critical biomarkers—estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 (ER/PR/HER2)—point treating physicians along appropriate care pathways in pursuit of optimal outcomes.

Currently available AI-aided scoring systems work well but can require additional...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Provider, Survey / Study, Technology, Trends, VA / DoD
Amazon invests another $2.75B in Anthropic — reportedly ‘largest’ in company history
Policy at global conference focuses on three central issues
How Remote Patient Monitoring and AI Personalize Care
How Nebraska Medicine used AI to reduce first-year nurse turnover by nearly 50%
Social Isolation Linked to Being Older Than Biological Age, Greater Mortality

Share This Article